The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
https://www.nature.com/articles/leu2017139.pdf
Reference72 articles.
1. Velazquez L . The Lnk adaptor protein: a key regulator of normal and pathological hematopoiesis. Arch Immunol Ther Exp (Warsz) 2012; 60: 415–429.
2. Huang X, Li Y, Tanaka K, Moore KG, Hayashi JI . Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1995; 92: 11618–11622.
3. Takaki S, Watts JD, Forbush KA, Nguyen NT, Hayashi J, Alberola-Ila J et al. Characterization of Lnk. An adaptor protein expressed in lymphocytes. J Biol Chem 1997; 272: 14562–14570.
4. Li Y, He X, Schembri-King J, Jakes S, Hayashi J . Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation. J Immunol 2000; 164: 5199–5206.
5. Fitau J, Boulday G, Coulon F, Quillard T, Charreau B . The adaptor molecule Lnk negatively regulates tumor necrosis factor-alpha-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and -2 pathways. J Biol Chem 2006; 281: 20148–20159.
Cited by 88 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypes;Leukemia Research;2024-08
2. Molecular Pathology of Myeloid Neoplasms;Clinics in Laboratory Medicine;2024-06
3. Advances in Molecular Understanding of Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis: Towards Precision Medicine;Cancers;2024-04-26
4. LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation;Cardiovascular Research;2024-02-20
5. Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment Advancements;Cancers;2024-01-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3